logo
My niece lives in a hospital — there might be nowhere else for her to go

My niece lives in a hospital — there might be nowhere else for her to go

Boston Globe19-03-2025

She has stayed in the hospital because she has nowhere to go — despite herculean efforts from her parents and the hospital. Caitlin was born with Cornelia de Lange syndrome (CdLS), a rare genetic condition, and they haven't found a facility that can handle her needs. She can't go home.
The National Institutes of Health
Get The Gavel
A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr.
Enter Email
Sign Up
CdLS causes a range of physical, medical, and mental challenges, but each case is different. Caitlin is on the severe end. Her growth is stunted: She is only 4 feet tall despite being 21 years old. She's on the autism spectrum and is nonverbal; it's estimated that her brain functioning is roughly that of a 1- or 2-year old. She has significant levels of hearing loss and visual impairment.
Advertisement
Because of a malformation of her digestive organs, she was fitted with a feeding tube when she was young. She is, as noted in her records, 'medically fragile' and has survived a host of medical issues, including septic shock, respiratory failure, and mini-strokes. Her parents have been working constantly from the moment she was born to keep her alive.
It's been more difficult than they imagined when they started this journey — not least because there are so few resources for kids and adults like Caitlin. With the Pappas Rehabilitation Hospital for Children, in Canton, slated for closure, there is about to be one fewer.
'We don't treat her any differently than anyone else'
When I first met Caitlin in 2009, I was visiting my future husband's family for the first time. He didn't tell me about her condition ahead of time. When I asked him why on the drive home, he replied, 'Caitlin's a part of our family — we don't treat her any differently than anyone else.'
Advertisement
Caitlin was 5 years old at the time but looked younger. She walked around, humming intermittently, with a musical toy held up to her ear (the better to hear the sound and experience the vibrations). Her parents, Steve and Sara Igoe, seemed stressed but cheerful, and their older daughter Lindsay sat nearby, quietly reading a book. A MassHealth personal care attendant followed Caitlin around and kept her from grabbing anything dangerous. Family members spoke to her lovingly, inquiring about what she was up to and giving her hugs when she passed by them.
Sara holds Caitlin's hand while she listens to the sounds produced by a toy.
Lane Turner/Globe Staff
She was full of personality. I could tell when she was feeling sunny or irritated. When it was the latter, she'd toss away her toy or cheekily knock something over. She was also sweet. At one point during my visit, she stopped and assessed me for a moment. Deeming my lap suitable for her purposes, she climbed into it for a momentary break.
But even then, Caitlin's parents were struggling to figure out how they would care for her as she grew. The prospect of her adulthood worried them most. In Sara's earliest conversations with the Department of Developmental Services in the 2010s, it had been made clear: There were limited spots available for adults in state-run residential facilities and group homes. For the best chance of placement, they'd need to make sure Caitlin was placed in a residential facility by the end of high school.
Advertisement
After years in her local school system, Caitlin began attending a residential program at the Perkins School for the Blind in 2016. The staff quickly recognized what her family had known for a long time: Her behaviors, including moans, grunts, and gesticulations, are her attempts to communicate. The teachers knew how to help, and Caitlin thrived. Her skills advanced, and the staff helped her parents implement an at-home communication system of pictures, objects, and basic American Sign Language.
For a time, things seemed challenging but manageable. That changed in 2022. She'd had surgery to remove some necrotic intestines a few years earlier, which led to complications, infections, more surgeries, and, eventually, a new kind of feeding tube. It suddenly became much more difficult to manage Caitlin's feeding process. Perkins didn't have the capacity to handle it, so she couldn't go back there.
Steve and Sara were desperately worried — it was back to the drawing board, with even fewer options than before. Finding a new facility took several months, even with help from DDS. In 2023, Caitlin finally began attending a school in Assonet that offered residential programs for children and adults with disabilities. They hoped she could stay there long-term.
That year, when I saw Caitlin during the holidays, she was visibly unhappy. Her parents shared that most of her progress in communicating was lost. She emitted low sounds that sounded like grunts until I realized, with a shock, that she was sobbing quietly to herself.
Just a few months later, she ended up in Boston Children's, for a stay that would last more than a year and counting.
Advertisement
Desperately searching for options
Caitlin now has almost no small intestine left, so doctors had to insert a central line to administer formula and medication. It's extremely delicate, because it needs to remain sterile at all times. But Caitlin finds it incredibly uncomfortable, so she pulls and scratches at it. When it's dislodged or dirty, it requires emergency sterilization due to the high risk of bloodstream infection. The central line dressing needs to be replaced once a week, a process to which Caitlin often reacts with aggressive agitation. It requires up to four medical professionals to complete the procedure.
Now, any illness is cause for concern. Specialists at Boston Children's have monitored her carefully, but she's still gotten pneumonia since she's been there. Despite her vulnerability to infection, staying at the hospital for the rest of her life is not a solution; a person with CdLS can live many years into adulthood.
Caitlin sits in her hospital room with her collection of sound-producing toys.
Lane Turner/Globe Staff
At-home care isn't an option, either. Her needs are too complicated. Although Caitlin's been approved for an at-home nurse, she's only eligible for 27 hours a week. And that nurse would not be able to manage her dressing changes and routine medical procedures alone. So Steve and Sara have gone searching, again, in vain, for another residential solution.
To date, they've reached out to 35 facilities, going as far as Pittsburgh to see if there's one that will accept Caitlin with her current needs. Few are able to handle a central line, and of those that are, Caitlin falls outside other criteria. For some facilities, her behaviors are too intense to manage effectively; for others, she's disqualified because she's ambulatory. She's not a great fit for a traditional nursing home because she's young, not to mention that she'd need communication and other support to thrive. But that might be her only other option anyway.
Advertisement
In late 2024, Caitlin was in the midst of an evaluation for the Pappas Rehabilitation Hospital. Caitlin's parents were hopeful; they'd heard good things. But Governor Maura Healey announced in January 2025 that the facility would be
In February, Sara heard from the Massachusetts Executive Office for Health and Human Services. They say they are working on a short- and long-term plan for placement, although there is nothing definite yet.
So, for the moment, Caitlin stays in the hospital, and she waits.
The wait
Caitlin is not alone. In early 2025, Sara reached out to the CdLS Facebook
Some recounted their own children aging out of or not qualifying for government programs or watching state-run facilities close and send their residents to private group homes. Many parents tried to care for their children at home because the facilities available to them were so low quality. (The Boston Globe
Caitlin rests in her hospital bed.
Lane Turner/Globe Staff
One parent in New England wrote, 'I feel like we're in an in-between place. The push for home- and community-based services has not caught up to the closing of institutions, leaving families with not enough supports or nothing.' Another parent added, 'They are, in my opinion, the forgotten.'
It is difficult to quantify the toll all of this has taken on Steve and Sara, on their well-being, their work, their relationship with Lindsay. They're exhausted. Of course they are.
They feel grateful, too. Not every family in this situation has the resources they do: for a patient advocate, long hospital stays, a flexible workplace. But after all of this, they vacillate between hope that a facility will materialize and fear that it never will.
'Sometimes we think to ourselves,
Let's just take her home and get her out of the hospital
. But then we worry something will happen, and she'll just end up back here," says Steve.
'The last three years have been the hardest,' adds Sara. She pauses. 'But it has really all been hard.'
Caitlin has done her part to fight, all her life, to exist among us. And her parents have fought on her behalf. It's hard to watch them and others like them fall through the cracks, and harder still to contemplate the possibility that they'll never have a reprieve.
For now, her extended family must stay at arm's length. My children ask to visit 'cousin Caitlin,' but we worry about getting her sick — so sick that she might not recover. We are all united in protecting this fierce, fragile girl.
I did manage a rare visit with Caitlin in early March. I watched the hospital staff change one of her dressings (aside from a central line, she has an additional tube for some medications). It required three medical professionals and one parent. Caitlin writhed and moaned when the nurses touched the tube lying flush with the irritated skin of her belly and as they gently wound gauze around the opening to contain leakage. Sara explained that it was often much worse, with Caitlin bucking and arching her back, tearing at her tube and trying to escape.
Stephen and Sara sit with their daughter in her hospital room.
Lane Turner/Globe Staff
When they were done, though, Caitlin was mostly back to her giggly self. She held a music toy to her face, meandered around the room stopping often to visit her parents, looked at me, and smiled. Just like old times, she spotted my lap, deemed it suitable, and plopped down onto it. I squeezed her tightly and hoped the next time I'd see her, it wouldn't be in a hospital room.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NIH Director Struggles To Defend His Own Plan To Slash $18 Billion In Medical Research
NIH Director Struggles To Defend His Own Plan To Slash $18 Billion In Medical Research

Yahoo

time2 hours ago

  • Yahoo

NIH Director Struggles To Defend His Own Plan To Slash $18 Billion In Medical Research

WASHINGTON ― National Institutes of Health director Jayanta Bhattacharya got a cool reception from Democratic and Republican senators on Tuesday as he defended his agency's budget request for 2026, which would slash billions in cutting-edge biomedical research on cancer, Alzheimer's disease, diabetes and other health conditions. NIH is considered the crown jewel of American science and the global leader in biomedical research and innovation. Senators in both parties are proud of its success and of their own roles in boosting its funding over the years in support of medical breakthroughs. So Bhattacharya had to know his budget request would land with a thud as he presented it to a Senate appropriations subcommittee. He kept trying to square two things that didn't make sense: that Trump is committed to preserving America's role as the leader in biomedical research, and that his proposed $18 billion in cuts to the agency next year ― or 40% of its entire budget ― won't hamper that. Senators didn't buy it. At times, Bhattacharya didn't seem to want to defend it, either. Sen. Susan Collins (R-Maine), who chairs the full Senate Appropriations Committee, called the administration's proposed cuts to NIH 'so disturbing.' 'It would undo years of congressional investment in NIH, and it would delay or stop effective treatments and cures from being developed for diseases,' Collins said. 'We also risk falling behind China and other countries that are increasing their investment in biomedical research.' In particular, she asked why the administration is calling for the cutting of funding by 40% for the National Institutes of Aging, which funds most Alzheimer's research, when it's been successfully developing breakthrough drugs and blood tests. Bhattacharya, without defending his own proposed cuts, said 'the intention' of the Trump administration is to lead the world in biomedical research, suggesting Congress could make a counteroffer and potentially propose more spending. 'The budget is a collaborative effort between the Congress and the administration,' he said. Collins simply replied, 'We look forward to working with you to remedy these problems and the deficiencies in the budget.' Sen. Patty Murray (D-Wash.), the top Democrat on the appropriations panel, ripped the administration's 'catastrophic' cuts to NIH to date. She said Trump has so far forced out nearly 5,000 employees, prevented nearly $3 billion in grants from being awarded, and terminated nearly 2,500 grants totaling almost $5 billion for life-saving research. 'The Trump administration is already systematically dismantling the American biomedical research enterprise that is the envy of the world, throwing away billions in economic activity in every one of our states,' Murray fumed. 'This budget proposal would effectively forfeit our leadership in research innovation and competitiveness to China.' She tangled with Bhattacharya over one of dozens of clinical trials that have been halted due to frozen NIH funds: a 23-year research effort to develop an HIV vaccine. Scientists there are on 'the cusp of a functional cure for HIV,' she said, and now 6,000 people in that trial have been cut off from treatment. Bhattacharya jumped in to say he is 'absolutely committed' to supporting research on HIV. 'But you did terminate the HIV research at Fred Hutch that, again, was on the cusp of a treatment for 6,000 patients nationwide,' Murray replied, referring to the Fred Hutchinson Cancer Research Center in Seattle. 'You did do that,' she said, as they talked over each other. 'I'd have to get back to you on that,' said Bhattacharya. 'You did do that,' she repeated. After more back and forth, the NIH director said again, 'The budget request is a work of negotiation between Congress and the administration.' Minutes later, he said it yet again, as Murray pressed for details on how many fewer clinical trials there would be next year because of the Trump administration's proposed cuts. 'I'll say this,' Bhattacharya declared. 'The budget itself is a negotiation between Congress and the administration.' He said it several other times, too. In fact, it became clear this was the NIH director's go-to line for defending his own devastating budget request. It simultaneously allowed him to stand by his bosses ― Trump, and Health and Human Services Secretary Robert F. Kennedy Jr. ― while not exactly arguing in support of its specific cuts. 'President Trump has committed that the U.S. be the leading nation in biomedicine in the 21st century,' he said at one point. 'I entirely support that goal.' 'Well, I do too, but it's hard to understand how we're going to get there when the budget slashes funding,' replied Sen. Jeanne Shaheen (D-N.H.). 'Particularly in critical areas of research where our most critical competitor, the Chinese, are increasing funding in those areas and we're slashing the budgets.' Bhattacharya didn't respond. It's possible he may not have agreed with some of his own budget's cuts. Bhattacharya certainly had a hand in crafting his agency's budget, but so did other officials at the White House and the Department of Health and Human Services. Before becoming NIH director in April, Bhattacharya was a professor of medicine, economics and health research policy at Stanford University. He knows how vital and highly esteemed NIH is, worldwide. Why not put it on Congress to save it? 'You say this is a collaborative effort, and you're absolutely right, and I encourage Congress to exert its authorities,' said Sen. Jerry Moran (R-Kansas). 'If Congress were to provide additional dollars above and beyond the president's budget request, how would we as a committee and how would you as NIH recommend for us to prioritize that spending?' Bhattacharya said he's focused on the 'real health needs' of Americans, like diabetes and cancer, and on the 'need to think big' for advancing science. 'Again, the budget, it's a collaborative effort,' he said. 'But I think it's going to be important that we address the real problems in science and the real needs of the American people with whatever budget comes out. That's my job.' Moran redirected Bhattacharya back to the need for more funding at NIH. 'I assume that means we need more resources,' said the Republican senator. 'And that you would put them to good use. Is that accurate?' 'That's my job,' replied the NIH director.

UAMS chancellor stepping down after 7 years, returning to faculty
UAMS chancellor stepping down after 7 years, returning to faculty

Yahoo

time3 hours ago

  • Yahoo

UAMS chancellor stepping down after 7 years, returning to faculty

UAMS Chancellor Cam Patterson announces a new $31.7 million grant from the National Institutes of Health on July 10, 2024. (Mary Hennigan/Arkansas Advocate) The leader of Arkansas' largest healthcare system will step down after seven years for personal and medical reasons, the University of Arkansas for Medical Sciences announced Tuesday in a news release. Dr. Cam Patterson became the university's chancellor in June 2018. By giving up his position as chancellor and as UAMS Health CEO, he will return to being a faculty member in the university's cardiology department. Patterson 'is facing medical and personal issues that require more attention than he can give them while serving in the chancellor's position,' according to UAMS' news release. 'The work our team has done at UAMS over the last seven-plus years has been the high point of my career,' Patterson said in the release. 'We have a lot to be proud of and I've been the luckiest guy to be a part of it. I am excited about the opportunity to return to the faculty and engage more deeply in the academic and clinical missions at our institution.' UAMS System President Jay Silveria praised Patterson's leadership tenure in the release. 'Leading UAMS is a demanding task, and I appreciate Dr. Patterson's need to do what he feels is best for himself and his family and for the long-term success of the university,' Silveria said. 'His contributions to UAMS came through unusually restrictive times, and he should be celebrated for his efforts to push the institution forward while navigating a challenging environment.' Patterson 'oversaw both challenges and improvement in the university's economic outlook, despite the myriad issues presented by the COVID-19 pandemic and other unforeseen variables,' the release states. One such challenge was a conflict between state and federal mandates regarding COVID-19 vaccinations. The federal Centers for Medicare and Medicaid Services issued a mandate in November 2021 for health workers to be fully vaccinated or receive exemptions, with noncompliant facilities at risk of losing federal funding. The rule directly conflicted with a 2021 Arkansas law that said COVID-19 vaccination 'shall not be a condition of education, employment, entry, or services from the state or a state agency or entity' unless lawmakers approved an exception. Patterson sought an exemption and defended this decision before a legislative committee. Silveria will name an interim UAMS chancellor 'in the coming weeks' and start a national search for Patterson's permanent successor, the news release states. SUPPORT: YOU MAKE OUR WORK POSSIBLE

Sen. Collins grills NIH director on research cuts
Sen. Collins grills NIH director on research cuts

Yahoo

time3 hours ago

  • Yahoo

Sen. Collins grills NIH director on research cuts

Jun. 10—Dr. Jay Bhattacharya, the new director of the National Institutes of Health, faced sharp questions from Sen. Susan Collins and other senators Tuesday about a proposed 40% budget reduction at the NIH and other cutbacks that are disrupting biomedical research. Bhattacharya appeared before the Senate Appropriations Committee's subcommittee on labor, health and human services and education on Tuesday as the Trump administration has slashed funding for biomedical research and public health. On Monday, hundreds of NIH scientists signed a letter, called the "Bethesda Declaration," asking the Trump administration to protect funding for biomedical research. Also Monday, Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns among public health advocates when he summarily dismissed all 17 members of a key committee that advises the government on approving vaccines. Kennedy, who has falsely questioned the safety and efficacy of vaccines, has not said who he would place on the Advisory Committee on Immunization Practices, which among other duties, recommends the formulation for the annual influenza vaccine. At the Senate hearing Tuesday, Bhattacharya largely dodged questions about the Trump administration's proposals to slash the agency, and the ongoing cuts to research grants. Collins, who voted to confirm Bhattacharya but has decried NIH cuts, questioned why the Trump administration is requesting a $19 billion cut to the NIH in the 2026 budget, which she said would "undo years of congressional investment." "It would delay or stop effective treatments and cures being developed for diseases like Alzheimer's, cancer and Type 1 diabetes," said Collins, who is chair of the Appropriations Committee. "We also risk falling behind China and other countries that are increasing their investment in biomedical research." Bhattacharya said the agency is "fully committed" to making progress on Alzheimer's and that the 2026 budget will be a "collaboration" between Congress and the White House. But, despite getting a series of questions from Collins and other Republican and Democratic senators, Bhattacharya did not specifically address the rationale for the budget cuts. Collins has also been speaking out for months against the agency's moves to cap the amount of money that biomedical researchers can use for indirect costs at no more than 15% of their NIH grants. The indirect costs include overhead expenses, equipment and technical support for scientific research and scientists say the cap would hobble research laboratories in Maine and across the country. The amount that NIH grants pay for indirect costs varies by grant, but made up 26% of the cost of each grant, on average, in 2023. Collins has also directly lobbied Kennedy to reverse the NIH cap on indirect costs, and Maine has joined other states in a lawsuit to block the cuts. On Tuesday, Collins said she is still "alarmed and surprised the administration's budget request (for next year) contains the same 15% cap." Bhattacharya said he couldn't discuss the indirect costs issue because of the pending lawsuit, but that there's "lots of great possibilities for reform" on how NIH awards grants for research. Sen. Tammy Baldwin, D-Wisconsin, also pointed out that the NIH has so far in 2025 spent $3 billion less on biomedical research compared to the same time in 2024, largely by freezing or denying grant funding on research that Congress previously approved. Much of the denied funding is the subject of pending lawsuits by states and universities that argue the Trump administration is illegally blocking the funding. The lawsuits argue that the executive branch is required to spend money that Congress approves, and the Trump administration does not have the power to block previously approved funding. "How is this anything other than sabotaging biomedical research?" Baldwin said. Bhattacharya did not answer, except to say he's "happy to work with Congress" on funding issues. Sen. Richard Durbin, D-Illinois, said the cuts to research are disturbing. "For God's sake, we lead the world in medical research. Why would we walk away from it?" Durbin said. Copy the Story Link

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store